2022
DOI: 10.1039/d1sc06722b
|View full text |Cite
|
Sign up to set email alerts
|

Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens

Abstract: PPh3-decorated mitochondrial-targeting AIEgens could fight metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 59 publications
1
13
0
Order By: Relevance
“…The reaction was mediated by the 1-ethyl-3-(3-dimethylamino)­propyl­carbodiimide (EDC)/ N -hydroxy­sulfosuccinimide (NHSS) method, obtaining ChiP (Figure S3). The presence of the phenyl proton peaks in the 1 H NMR spectrum shows that PPh 3 was successfully grafted to the final polymers ChiP (Figure S4), which is consistent with previous studies of characterization. …”
Section: Resultssupporting
confidence: 90%
“…The reaction was mediated by the 1-ethyl-3-(3-dimethylamino)­propyl­carbodiimide (EDC)/ N -hydroxy­sulfosuccinimide (NHSS) method, obtaining ChiP (Figure S3). The presence of the phenyl proton peaks in the 1 H NMR spectrum shows that PPh 3 was successfully grafted to the final polymers ChiP (Figure S4), which is consistent with previous studies of characterization. …”
Section: Resultssupporting
confidence: 90%
“…However, cancer cells can develop metal drug resistance after multiple rounds of treatment, greatly limiting the efficacy of treatment, which is no exception for lung cancer treatment [ 173 ]. To overcome cisplatin resistance, Su et al proposed a new strategy to solve the problem through mitochondrial dysfunction according to the anticancer mechanism of cisplatin (cis-Pt) [ 174 ]. Two mitochondria-targeted AIE molecules, DP-PPh 3 and TPE-PPh 3 , demonstrated superior ability to overcome cisplatin resistance in lung cancer cells (A549R) by altering drug metabolism (up-regulation of influx CTR1 and down-regulation of efflux MRP2) and blocking autophagy flux (failure of the degradation of autophagosomes).…”
Section: Aie-pss For Different Cancers Treatmentmentioning
confidence: 99%
“…The assembly of PTPE salts with different alkyl chain lengths and counter anions under different conditions was further explored [ 100 ], and the targetability and imaging ability of mitochondria are ascribed to AIE effects, which are promising for cancer therapy. In a recent study, Su et al developed AIEgens for the treatment of cis -platin-resistant cancer cells for the first time, which can induce ROS production and disrupt the mitochondrial structure, impairing mitochondrial and glycolytic metabolism [ 101 ]. Chemotherapeutic agents with AIE properties and anticancer activity offer a promising platform for integrating diagnosis and treatment.…”
Section: Aiegen-based Assembly For Theranostic Applicationsmentioning
confidence: 99%